Astellas Pharma Inc (ALPMY)
9.55
+0.01
(+0.10%)
USD |
OTCM |
Apr 26, 16:00
Astellas Pharma EPS Diluted (Quarterly): 0.0546 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0546 |
| September 30, 2023 | -0.0056 |
| June 30, 2023 | 0.1342 |
| March 31, 2023 | -0.1916 |
| December 31, 2022 | 0.1883 |
| September 30, 2022 | 0.2843 |
| June 30, 2022 | 0.1049 |
| March 31, 2022 | -0.0381 |
| December 31, 2021 | 0.2889 |
| September 30, 2021 | 0.2006 |
| June 30, 2021 | 0.1512 |
| March 31, 2021 | -0.0626 |
| December 31, 2020 | 0.3096 |
| September 30, 2020 | 0.1137 |
| June 30, 2020 | 0.252 |
| March 31, 2020 | 0.0293 |
| December 31, 2019 | 0.3015 |
| September 30, 2019 | 0.3459 |
| June 30, 2019 | 0.2821 |
| March 31, 2019 | 0.149 |
| December 31, 2018 | 0.4045 |
| September 30, 2018 | 0.2285 |
| June 30, 2018 | 0.2535 |
| March 31, 2018 | 0.1039 |
| December 31, 2017 | 0.2654 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.1746 |
| June 30, 2017 | 0.1849 |
| March 31, 2017 | 0.1696 |
| December 31, 2016 | 0.2767 |
| September 30, 2016 | 0.2225 |
| June 30, 2016 | 0.2899 |
| March 31, 2016 | 0.1198 |
| December 31, 2015 | 0.2357 |
| September 30, 2015 | 0.2203 |
| June 30, 2015 | 0.1678 |
| March 31, 2015 | 0.0807 |
| December 31, 2014 | 0.177 |
| September 30, 2014 | 0.1485 |
| June 30, 2014 | 0.1579 |
| March 31, 2014 | 0.0329 |
| December 31, 2013 | 0.5908 |
| September 30, 2013 | 0.1152 |
| June 30, 2013 | 0.0889 |
| March 31, 2013 | 0.0377 |
| December 31, 2012 | 0.1461 |
| September 30, 2012 | 0.1207 |
| June 30, 2012 | 0.1915 |
| March 31, 2012 | -0.1099 |
| December 31, 2011 | 0.2645 |
| September 30, 2011 | 0.1459 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.1916
Minimum
Mar 2023
0.3459
Maximum
Sep 2019
0.1444
Average
0.1512
Median
Jun 2021
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.2265 |
| Nxera Pharma Co Ltd | -0.0144 |
| PeptiDream Inc | -0.0263 |
| Stemcell Holdings Inc | 0.04 |
| Healios KK | -0.1655 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 98.29M |
| Revenue (Quarterly) | 2.858B |
| Total Expenses (Quarterly) | 2.730B |
| Enterprise Value | 21.28B |
| Gross Profit Margin (Quarterly) | 82.01% |
| Profit Margin (Quarterly) | 3.44% |
| Earnings Yield | -0.09% |
| Operating Earnings Yield | 0.40% |
| Normalized Earnings Yield | -0.3897 |